Clinical Research Directory
Browse clinical research sites, groups, and studies.
Descemet Endothelial Thickness Comparison Trial II
Sponsor: Stanford University
Summary
Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.
Official title: Descemet Endothelial Thickness Comparison Trials (DETECT I & II)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-01-23
Completion Date
2028-11-30
Last Updated
2025-12-18
Healthy Volunteers
No
Interventions
Ripasudil
Topical Ripasudil 0.4%
Placebo
Topical Placebo
Locations (7)
Stanford University
Palo Alto, California, United States
University of California Davis
Sacramento, California, United States
University of Miami
Palm Beach Gardens, Florida, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Oregon Health & Science University
Portland, Oregon, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Wills Eye Hospital
Philadelphia, Pennsylvania, United States